Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P Hadji, R E Coleman, C Wilson, et al.
ESMO Open
|
August 15, 2025
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)
M Hamann, M Christgen, O Gluz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02
S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2026
Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N=7914)
O Gluz, U Nitz, M Christgen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 8, 2017
Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres
P A van Dam, M Tomatis, L Marotti, et al.
ESMO Open
|
December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group
S P Gampenrieder, V Dezentjé, M Lambertini, et al.
Breast (Edinburgh, Scotland)
|
March 20, 2012
1st International consensus guidelines for advanced breast cancer (ABC 1)
F Cardoso, A Costa, L Norton, et al.
ESMO Open
|
May 25, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer
K H Park, S Loibl, J Sohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2021
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
N Harbeck, P Rastogi, M Martin, et al.
ESMO Open
|
May 13, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer
S-A Im, A Gennari, Y H Park, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P Hadji, R E Coleman, C Wilson, et al.
ESMO Open
|
August 15, 2025
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)
M Hamann, M Christgen, O Gluz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02
S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2026
Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N=7914)
O Gluz, U Nitz, M Christgen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 8, 2017
Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres
P A van Dam, M Tomatis, L Marotti, et al.
ESMO Open
|
December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group
S P Gampenrieder, V Dezentjé, M Lambertini, et al.
Breast (Edinburgh, Scotland)
|
March 20, 2012
1st International consensus guidelines for advanced breast cancer (ABC 1)
F Cardoso, A Costa, L Norton, et al.
ESMO Open
|
May 25, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer
K H Park, S Loibl, J Sohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2021
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
N Harbeck, P Rastogi, M Martin, et al.
ESMO Open
|
May 13, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer
S-A Im, A Gennari, Y H Park, et al.
Page
of 15